用以治療與嗜中性白血球激活失調及趨化相關之疾病的方法

Tsong-Long Hwang; TING-I KAO; TIAN-SHUNG WU

用以治療與嗜中性白血球激活失調及趨化相關之疾病的方法

Translated title of the contribution: METHODS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DYSREGULATED ACTIVATION AND RECRUITMENT OF NEUTROPHILS

Tsong-Long Hwang (Inventor), TING-I KAO (Inventor), TIAN-SHUNG WU (Inventor)

School of Traditional Chinese Medicine

Research output: Patent

Abstract

Disclosed herein is a novel use of 3,3’-dihydroxy-2’,6’-bis(p-hydroxybenzyl)-5-methoxybibenzyl (or bletinib), a salt, a solvate or an ester thereof for manufacturing a medicament suitable for the treatment of diseases and/or disorders associated with the dysregulated activation and recruitment of neutrophils, such as acute lung injury (ALI).

Translated title of the contribution	METHODS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DYSREGULATED ACTIVATION AND RECRUITMENT OF NEUTROPHILS
Original language	Chinese (Traditional)
IPC	A61K 31/05(2006.01); A61P 11/00(2006.01)
State	Published - 01 11 2022

Bibliographical note

公開公告號: 2.02241392E8
Announcement ID: 2.02241392E8

Cite this

@misc{ca6220c9cf25489f922992126cc43e86,

title = "用以治療與嗜中性白血球激活失調及趨化相關之疾病的方法",

abstract = "本發明公開了3，3'-二羥基-2'，6'-雙(對羥基芐基)-5-甲氧基二芐基(或布列替尼)、其鹽、溶劑合物或酯於製備藥物上的新用途，此藥物適用於治療與嗜中性白血球激活失調及趨化相關之疾病和/或障礙，例如急性肺損傷(acute lung injury， ALI)。",

author = "Tsong-Long Hwang and TING-I KAO and TIAN-SHUNG WU",

note = "A61K 31/05(2006.01); A61P 11/00(2006.01)",

year = "2022",

month = nov,

day = "1",

language = "繁體中文",

type = "Patent",

}

TY - PAT

T1 - 用以治療與嗜中性白血球激活失調及趨化相關之疾病的方法

AU - Hwang, Tsong-Long

AU - KAO, TING-I

AU - WU, TIAN-SHUNG

N1 - 公開公告號: 2.02241392E8 Announcement ID: 2.02241392E8

PY - 2022/11/1

Y1 - 2022/11/1

N2 - 本發明公開了3，3'-二羥基-2'，6'-雙(對羥基芐基)-5-甲氧基二芐基(或布列替尼)、其鹽、溶劑合物或酯於製備藥物上的新用途，此藥物適用於治療與嗜中性白血球激活失調及趨化相關之疾病和/或障礙，例如急性肺損傷(acute lung injury， ALI)。

AB - 本發明公開了3，3'-二羥基-2'，6'-雙(對羥基芐基)-5-甲氧基二芐基(或布列替尼)、其鹽、溶劑合物或酯於製備藥物上的新用途，此藥物適用於治療與嗜中性白血球激活失調及趨化相關之疾病和/或障礙，例如急性肺損傷(acute lung injury， ALI)。

M3 - 專利

ER -

用以治療與嗜中性白血球激活失調及趨化相關之疾病的方法

Abstract

Bibliographical note

Fingerprint

Cite this